100 related articles for article (PubMed ID: 1755684)
1. Cardioprotective effects of nucleoside transport inhibition in rabbit hearts.
Masuda M; Demeulemeester A; Chen CC; Hendrikx M; Van Belle H; Flameng W
Ann Thorac Surg; 1991 Dec; 52(6):1300-5. PubMed ID: 1755684
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and functional effects of the nucleoside transport inhibitor R75231 in the ischaemic and blood reperfused rabbit heart.
Galiñanes M; Qiu Y; Van Belle H; Hearse DJ
Cardiovasc Res; 1993 Jan; 27(1):90-5. PubMed ID: 8458038
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside transport inhibition mediates lidoflazine-induced cardioprotection during intermittent aortic crossclamping.
Chang-Chun C; Masuda M; Szabò Z; Szerafin T; Szècsi J; Van Belle H; Flameng W
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1602-9. PubMed ID: 1453724
[TBL] [Abstract][Full Text] [Related]
4. Effect of nucleoside transport inhibition on adenosine and hypoxanthine accumulation in the ischemic human myocardium.
Masuda M; Sukehiro S; Möllhoff T; Van Belle H; Flameng W
Arch Int Pharmacodyn Ther; 1993; 322():45-54. PubMed ID: 8215716
[TBL] [Abstract][Full Text] [Related]
5. Improvement in functional recovery of the isolated guinea pig heart after hyperkalemic reperfusion with adenosine.
Habazettl H; Palmisano BW; Graf BM; Roerig DL; Bosnjak ZJ; Stowe DF
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):74-84. PubMed ID: 8551791
[TBL] [Abstract][Full Text] [Related]
6. Effects of nucleoside transport inhibition on long-term ex vivo preservation of canine hearts.
Masuda M; Chang-Chun C; Möllhoff T; Van Belle H; Flameng W
J Thorac Cardiovasc Surg; 1992 Dec; 104(6):1610-7. PubMed ID: 1453725
[TBL] [Abstract][Full Text] [Related]
7. Successful transplantation after long-term preservation of dog hearts.
Möllhoff T; Sukehiro S; Van Belle H; Van Aken H; Flameng W
Anesthesiology; 1992 Aug; 77(2):291-300. PubMed ID: 1642349
[TBL] [Abstract][Full Text] [Related]
8. Intermittent aortic crossclamping prevents cumulative adenosine triphosphate depletion, ventricular fibrillation, and dysfunction (stunning): is it preconditioning?
Abd-Elfattah AS; Ding M; Wechsler AS
J Thorac Cardiovasc Surg; 1995 Aug; 110(2):328-39. PubMed ID: 7637350
[TBL] [Abstract][Full Text] [Related]
9. The differential cardioprotective effects of nucleoside transport inhibitor on moderate and deep hypothermic ischemia with cold cardioplegia.
Nishida T; Masuda M; Kanegae Y; Miyamoto K; Tominaga R; Kawachi Y; Yasui H
Surg Today; 2000; 30(9):805-10. PubMed ID: 11039708
[TBL] [Abstract][Full Text] [Related]
10. Differential cardioprotection with selective inhibitors of adenosine metabolism and transport: role of purine release in ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Lekven J; Wechsler AS
Mol Cell Biochem; 1998 Mar; 180(1-2):179-91. PubMed ID: 9546645
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and functional effects of nucleoside transport inhibition in the isolated cat heart.
Van Belle H; Goossens F; Wynants J
J Mol Cell Cardiol; 1989 Aug; 21(8):797-805. PubMed ID: 2778816
[TBL] [Abstract][Full Text] [Related]
12. Protection against injury during ischemia and reperfusion by acadesine derivatives GP-1-468 and GP-1-668. Studies in the transplanted rat heart.
Galiñanes M; Zhai X; Bullough D; Mullane KM; Hearse DJ
J Thorac Cardiovasc Surg; 1995 Sep; 110(3):752-61. PubMed ID: 7564443
[TBL] [Abstract][Full Text] [Related]
13. Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine. Possible separation between ischemic and reperfusion injury.
Abd-Elfattah AS; Jessen ME; Wechsler AS
J Thorac Cardiovasc Surg; 1994 Aug; 108(2):269-78. PubMed ID: 8041175
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism.
Woolfson RG; Patel VC; Neild GH; Yellon DM
Circulation; 1995 Mar; 91(5):1545-51. PubMed ID: 7867197
[TBL] [Abstract][Full Text] [Related]
15. Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.
Itoya M; Miura T; Sakamoto J; Urabe K; Iimura O
J Cardiovasc Pharmacol; 1994 Nov; 24(5):846-52. PubMed ID: 7532764
[TBL] [Abstract][Full Text] [Related]
16. Muscarinic receptor stimulation by carbachol improves functional recovery in isolated, blood perfused rabbit heart.
Hendrikx M; Toshima Y; Mubagwa K; Flameng W
Cardiovasc Res; 1993 Jun; 27(6):980-9. PubMed ID: 8221789
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of ischemic injury with nucleosides.
De Jong JW; Van der Meer P; Owen P; Opie LH
Bratisl Lek Listy; 1991; 92(3-4):165-73. PubMed ID: 2029658
[TBL] [Abstract][Full Text] [Related]
18. The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs.
Wainwright CL; Parratt JR; Van Belle H
Br J Pharmacol; 1993 Jun; 109(2):592-9. PubMed ID: 8358559
[TBL] [Abstract][Full Text] [Related]
19. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection.
Goto M; Cohen MV; van Wylen DG; Downey JM
J Mol Cell Cardiol; 1996 Mar; 28(3):447-54. PubMed ID: 9011628
[TBL] [Abstract][Full Text] [Related]
20. Cardiac-derived thromboxane A2. An initiating mediator of reperfusion injury?
Byrne JG; Appleyard RF; Sun SC; Couper GS; Sloane JA; Laurence RG; Cohn LH
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):689-93. PubMed ID: 8469003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
